Skip to main content
Top
Published in: Diagnostic Pathology 1/2016

Open Access 01-12-2016 | Case Report

Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy

Authors: Maria Carolina Wilhelmina Salet, Rob Vogels, Paul Brons, Bart Schreuder, Uta Flucke

Published in: Diagnostic Pathology | Issue 1/2016

Login to get access

Abstract

Background

Ewing sarcoma is the second most common bone tumor, occurring mainly in children and young adults. It shows a typical primitive, small round cell morphology and a characteristic fusion oncogene involving EWSR1 and members of the ETS family in most of the cases. Neuronal maturation after chemotherapy is a rare phenomenon and we herein describe such an exceptional case.

Case presentation

An 8-year old boy was diagnosed with a Ewing sarcoma in the left femur. On biopsy the morphology was typical and there was an EWSR1-FLI1 gene fusion. He underwent neo-adjuvant chemotherapy and resection of the tumor. On microscopic evaluation, part of the tumor showed ganglioneuroblastoma-like differentiation with expression of neuronal markers. The continued presence of EWSR1 rearrangement in both the blue round cell component and the ganglioneuroblastoma-like component was shown by FISH analysis.

Conclusions

In conclusion, this case describes the possibility of a Ewing sarcoma to differentiate into a ganglioneuroblastoma-like lesion after neo-adjuvant chemotherapy treatment; the prognostic value of this phenomenon remains questionable.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hamilton SN et al. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma. Am J Clin Oncol. 2015. Hamilton SN et al. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma. Am J Clin Oncol. 2015.
2.
go back to reference Rodriguez-Galindo C, et al. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children’s Research Hospital studies. Cancer. 2007;110(2):375–84.CrossRefPubMed Rodriguez-Galindo C, et al. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children’s Research Hospital studies. Cancer. 2007;110(2):375–84.CrossRefPubMed
3.
go back to reference Collini P, et al. Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone. Am J Surg Pathol. 2003;27(8):1161–6.CrossRefPubMed Collini P, et al. Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone. Am J Surg Pathol. 2003;27(8):1161–6.CrossRefPubMed
4.
go back to reference Arvand A, Denny CT. Biology of EWS/ETS fusions in Ewing’s family tumors. Oncogene. 2001;20(40):5747–54.CrossRefPubMed Arvand A, Denny CT. Biology of EWS/ETS fusions in Ewing’s family tumors. Oncogene. 2001;20(40):5747–54.CrossRefPubMed
5.
go back to reference Maeda G, et al. Ganglion cells in Ewing’s sarcoma following chemotherapy: a case report. Pathol Int. 1998;48(6):475–80.CrossRefPubMed Maeda G, et al. Ganglion cells in Ewing’s sarcoma following chemotherapy: a case report. Pathol Int. 1998;48(6):475–80.CrossRefPubMed
7.
go back to reference von Levetzow C, et al. Modeling initiation of Ewing sarcoma in human neural crest cells. PLoS One. 2011;6(4):e19305.CrossRef von Levetzow C, et al. Modeling initiation of Ewing sarcoma in human neural crest cells. PLoS One. 2011;6(4):e19305.CrossRef
8.
go back to reference Delattre O, et al. The Ewing Family of Tumors - a Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts. N Engl J Med. 1994;331(5):294–9.CrossRefPubMed Delattre O, et al. The Ewing Family of Tumors - a Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts. N Engl J Med. 1994;331(5):294–9.CrossRefPubMed
9.
go back to reference Burchill SA, et al. EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma. Eur J Cancer. 1997;33(2):239–43.CrossRefPubMed Burchill SA, et al. EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma. Eur J Cancer. 1997;33(2):239–43.CrossRefPubMed
10.
go back to reference Coffin CM, et al. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis. Mod Pathol. 1997;10(12):1175–87.PubMed Coffin CM, et al. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis. Mod Pathol. 1997;10(12):1175–87.PubMed
11.
go back to reference Smith LM, Anderson JR, Coffin CM. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS). Med Pediatr Oncol. 2002;38(6):398–404.CrossRefPubMed Smith LM, Anderson JR, Coffin CM. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS). Med Pediatr Oncol. 2002;38(6):398–404.CrossRefPubMed
12.
go back to reference Lowichik A, et al. Therapy associated changes in childhood tumors. Adv Anat Pathol. 2000;7(6):341–59.CrossRefPubMed Lowichik A, et al. Therapy associated changes in childhood tumors. Adv Anat Pathol. 2000;7(6):341–59.CrossRefPubMed
13.
go back to reference Molenaar WM, Oosterhuis JW, Kamps WA. Cytologic “differentiation” in childhood rhabdomyosarcomas following polychemotherapy. Hum Pathol. 1984;15(10):973–9.CrossRefPubMed Molenaar WM, Oosterhuis JW, Kamps WA. Cytologic “differentiation” in childhood rhabdomyosarcomas following polychemotherapy. Hum Pathol. 1984;15(10):973–9.CrossRefPubMed
14.
go back to reference Arndt CA, et al. Significance of persistent mature rhabdomyoblasts in bladder/prostate rhabdomyosarcoma: Results from IRS IV. J Pediatr Hematol Oncol. 2006;28(9):563–7.CrossRefPubMed Arndt CA, et al. Significance of persistent mature rhabdomyoblasts in bladder/prostate rhabdomyosarcoma: Results from IRS IV. J Pediatr Hematol Oncol. 2006;28(9):563–7.CrossRefPubMed
Metadata
Title
Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy
Authors
Maria Carolina Wilhelmina Salet
Rob Vogels
Paul Brons
Bart Schreuder
Uta Flucke
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2016
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-016-0516-0

Other articles of this Issue 1/2016

Diagnostic Pathology 1/2016 Go to the issue